ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

PTN Palatin Technologies Inc New

1.827
0.107 (6.22%)
2024年4月27日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Palatin Technologies Inc New PTN AMEX 普通株式
  前日比 前日比 % 現在値 時刻
0.107 6.22% 1.827 09:00:00
始値 安値 高値 終値 前日終値
1.72 1.68 1.83 1.82 1.72
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/0820:30PRNUSPalatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease..
2024/3/0807:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0502:57EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2821:30PRNUSPalatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3..
2024/2/1523:00EDGAR2Form 8-K - Current report
2024/2/1521:30PRNUSPalatin Reports Second Quarter Fiscal Year 2024 Financial..
2024/2/1506:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/2/1504:55EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0921:30PRNUSPalatin to Report Second Quarter Fiscal Year 2024 Results;..
2024/2/0521:30PRNUSPalatin Announces Database Lock for PL9643 MELODY-1 Pivotal..
2024/2/0207:16EDGAR2Form 8-K - Current report
2024/2/0206:00PRNUSPalatin Announces Closing of $10 Million Registered Direct..
2024/1/3022:00PRNUSPalatin Announces $10 Million Registered Direct Offering
2024/1/0900:33PRNUSPalatin Provides Corporate Update and Highlights Strategic..
2024/1/0322:00BWCosette Pharmaceuticals Acquires Vyleesi® (Bremelanotide..
2023/12/2023:00EDGAR2Form 8-K - Current report
2023/12/2021:30PRNUSPalatin Completes Sale of Vyleesi® to Cosette..
2023/12/1906:45EDGAR2Form 8-K - Current report
2023/12/1906:15PRNUSPalatin Receives Notice of Acceptance of the Listing..
2023/12/1814:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/12/0907:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0707:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0704:25EDGAR2Form 144 - Report of proposed sale of securities
2023/12/0507:00EDGAR2Form S-1 - General form for registration of securities under..
2023/12/0205:52EDGAR2Form 144 - Report of proposed sale of securities
2023/11/1421:30PRNUSPalatin Reports First Quarter Fiscal Year 2024 Financial..
2023/11/0921:30PRNUSPalatin to Report First Quarter Fiscal Year 2024 Results;..
2023/10/2505:50PRNUSPalatin Announces Closing of $5 Million Registered Direct..
2023/10/2505:05EDGAR2Form 8-K - Current report
2023/10/2320:30PRNUSPalatin Announces $5 Million Registered Direct Offering
2023/10/1921:01EDGAR2Form 8-K - Current report
2023/10/1920:30PRNUSPalatin Announces Preliminary Quarter Ended September 30,..
2023/10/1820:30PRNUSPalatin Announces Positive Preclinical Data Showing..
2023/10/1620:30PRNUSPalatin Presents Data at the United European..
2023/10/1405:31EDGAR2Form 8-K - Current report
2023/10/1405:15PRNUSPalatin Receives Notice of Non-Compliance from NYSE American
2023/9/2821:02EDGAR2Form 8-K - Current report
2023/9/2821:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2023/9/2820:30PRNUSPalatin Reports Fourth Quarter and Fiscal Year Ended 2023..
2023/9/2305:00PRNUSPalatin to Report Fourth Quarter and Fiscal Year End 2023..
2023/9/0821:00EDGAR2Form 8-K - Current report
2023/9/0805:00PRNUSPalatin to Present at the H.C. Wainwright 25th Annual Global..
2023/9/0721:49EDGAR2Form 8-K - Current report
2023/9/0720:30PRNUSPalatin Completes Enrollment in Phase 3 MELODY-1 Study of..
2023/8/1710:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1710:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1021:15EDGAR2Form 8-K - Current report
2023/8/1020:30PRNUSPalatin Initiates Clinical Program for Bremelanotide..
2023/8/0821:00EDGAR2Form 8-K - Current report
2023/8/0820:30PRNUSPalatin's Vyleesi® Licensee Fosun Pharma Reports First..

最近閲覧した銘柄

Delayed Upgrade Clock